agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
27.90
+2.58 (10.19%)
At close: Apr 28, 2026, 4:00 PM EDT
29.30
+1.40 (5.02%)
After-hours: Apr 28, 2026, 4:13 PM EDT
agilon health Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for agilon health stock have an average target of 55.68, with a low estimate of 12.5 and a high estimate of 187.5. The average target predicts an increase of 99.57% from the current stock price of 27.90.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for agilon health stock from 12 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Hold | 15 | 13 | 13 | 10 | 10 | 8 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 18 | 18 | 14 | 14 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Maintains $1.5 → $13 | Strong Buy | Maintains | $1.5 → $13 | -53.41% | Apr 2, 2026 |
| Citigroup | Citigroup | Hold Maintains $21 → $19 | Hold | Maintains | $21 → $19 | -32.80% | Mar 3, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $25 → $38 | Buy | Maintains | $25 → $38 | +34.41% | Feb 27, 2026 |
| Barclays | Barclays | Sell Maintains $25 → $13 | Sell | Maintains | $25 → $13 | -55.20% | Feb 27, 2026 |
| BTIG | BTIG | Hold Suspends n/a | Hold | Suspends | n/a | n/a | Dec 12, 2025 |
Financial Forecast
Revenue This Year
5.51B
from 5.93B
Decreased by -7.14%
Revenue Next Year
5.74B
from 5.51B
Increased by 4.23%
EPS This Year
-5.93
from -23.63
EPS Next Year
-4.62
from -5.93
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 5.8B | 6.4B | ||||
| Avg | 5.5B | 5.7B | ||||
| Low | 5.3B | 5.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -2.7% | 15.4% | ||||
| Avg | -7.1% | 4.2% | ||||
| Low | -10.6% | -7.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.82 | -1.35 | |
| Avg | -5.93 | -4.62 | |
| Low | -10.22 | -7.21 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.